Secondary adrenal insufficiency medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 47: Line 47:


==Medical Therapy==
==Medical Therapy==
*Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].
*Pharmacologic medical therapies for secondary adrenal insufficiency include [[Hydrocortisone]]
*Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].
*Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].
*Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].


==== '''Secondary adrenal insufficiency''' ====
==== '''Secondary adrenal insufficiency''' ====
** Preferred regimen : [[Hydrocortisone]] 15-25 mg PO q8-12h till the symptoms resolve
* Preferred regimen: [[Hydrocortisone]] 15-25 mg PO q8-12h till the symptoms resolve
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 13:54, 3 October 2017

Adrenal insufficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Secondary adrenal insufficiency medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Secondary adrenal insufficiency medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Secondary adrenal insufficiency medical therapy

CDC on Secondary adrenal insufficiency medical therapy

Secondary adrenal insufficiency medical therapy in the news

Blogs on Secondary adrenal insufficiency medical therapy

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Secondary adrenal insufficiency medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is no treatment for [disease name]; the mainstay of therapy is supportive care.

OR

Supportive therapy for [disease name] includes [therapy 1], [therapy 2], and [therapy 3].

OR

The majority of cases of [disease name] are self-limited and require only supportive care.

OR

[Disease name] is a medical emergency and requires prompt treatment.

OR

The mainstay of treatment for [disease name] is [therapy].

OR   The optimal therapy for [malignancy name] depends on the stage at diagnosis.

OR

[Therapy] is recommended among all patients who develop [disease name].

OR

Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].

OR

Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].

OR

Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].

OR

Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].

Medical Therapy

  • Pharmacologic medical therapies for secondary adrenal insufficiency include Hydrocortisone

Secondary adrenal insufficiency

  • Preferred regimen: Hydrocortisone 15-25 mg PO q8-12h till the symptoms resolve

References


Template:WikiDoc Sources